Neesgaard et al., Integrase-Hemmer und Herz-Kreislauf-Erkrankungen
Zusammenhänge zwischen Integrase-Hemmer und Herz-Kreislauf-Erkrankungen bei Menschen mit HIV: eine prospektive Multicenter-Studie des RESPOND-Kohortenkonsortiums. Lancet HIV Herz-Kreislauf-Erkrankungen sind ein wichtiges Thema bei der Betreuung von Menschen, die mit HIV leben. Seit dem breiten Zugang zu antiretroviralen Medikamenten ist die Lebenserwartung von Menschen mit HIV stetig gestiegen, wodurch sie auch anfälliger für kardiometabolische Nebenwirkungen der Medikamente […]
Greenberg et al., Trends in cancer incidence in different ART-eras amongst PWH
Trends in cancer incidence in different antiretroviral treatment-eras amongst people with HIV. Cancers Greenberg et al. on behalf of the RESPOND and D:A:D Study Groups aimed to assess changes in the incidence of both overall cancer and different types of cancer, including AIDS-defining cancers (ADCs), non-ADCs (NADCs), infection-related cancers, body mass index (BMI)-related cancers, and […]
Neesgaard et al., Les inhibiteurs de l’intégrase et les maladies cardiovasculaires
Association entre les inhibiteurs de l’intégrase et les maladies cardiovasculaires chez les personnes vivant avec le VIH: une étude prospective multicentrique du consortium de la cohorte RESPOND. Lancet HIV Les maladies cardiovasculaires font partie des préoccupations majeures durant le suivi des personnes vivant avec le VIH (PVVIH). En effet, depuis l’accès universel aux traitements […]
Balakrishna et al., Comparison of HIV drug resistance mutation detection methods
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1. Journal of Antimicrobial Chemotherapy Balakrishna et al. aimed to compare the HIV drug resistance mutations (DRMs) detected by Sanger sequencing (SS) and next-generation sequencing (NGS) at different thresholds and explored the dependency of the frequency and spectrum of low-abundance HIV-DRMs […]
Ingle et al., Treating HIV in cryptococcal meningitis
Early antiretroviral therapy not associated with higher cryptococcal meningitis mortality in people with HIV in high-income countries: an international collaborative cohort study. Clinical Infectious Disease Ingle et al. aimed to investigate the impact of antiretroviral therapy (ART) timing on mortality rates associated with cryptococcal meningitis (CM) among people in high-income settings. The authors used […]
Mugglin and Hamusonde et al., MSM with HIV in times of COVID-19
Sexual behaviour and STI Incidence in sexually active MSM living with HIV in times of COVID-19. Open Forum Infectious Diseases Mugglin and Hamusonde et al. evaluated changes in sexual behavior, satisfaction and incidence of sexually transmitted infections among men who have sex with men (MSM) related to restrictions due to the COVID-19 pandemic. All […]
Filippidis et al., CSF HIV-1 escape in cognitive symptoms
Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: Pooled data from a neuro-HIV platform and the NAMACO Study. JAIDS Filippidis et al. for the NAMACO study group aimed to evaluate the prevalence of cerebrospinal fluid (CSF) HIV-1 escape among people living with HIV (PLWH) in Switzerland and to identify potential predictive factors and clinical […]
Damas et al., Neuro-HIV multidisciplinary platform for PLWH
One for all, all for one: neuro-HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV. HIV Medicine Damas et al. describe the implementation of a multidisciplinary neuro-HIV platform, which aims at providing a comprehensive neurocognitive assessment. In the Lausanne University Hospital (CHUV), specialists from the departments of […]
Byonanebye et al., Ipertensione arteriosa e inibitori dell’integrasi nelle persone che vivono con l’HIV
Ipertensione arteriosa e inibitori dell’integrasi nelle persone che vivono con l’HIV. HIV Medicine L’ipertensione arteriosa è una delle principali cause di decesso prematuro in tutto il mondo e rappresenta un problema crescente nelle persone che vivono con l’HIV (PVHIV). Circa un terzo delle PVHIV nel mondo soffrono di ipertensione arteriosa. Esistono già dati convincenti che […]
Byonanebye et al., Bluthochruck und Integrase-Hemmer bei Menschen mit HIV
Bluthochruck und Integrase-Hemmer bei Menschen mit HIV. HIV Medicine Bluthochdruck ist weltweit eine der Hauptursachen für vorzeitige Todesfälle und ein zunehmendes Problem bei Menschen, die mit HIV leben. Weltweit leiden etwa ein Drittel aller erwachsenen Menschen mit HIV unter Bluthochdruck. Es gibt bereits klare Hinweise darauf, dass die HIV-Medikamente aus der Klasse der Integrase-Hemmer mit […]